Quality & Regulatory Affairs – Director
Pending…
Pending…
OncoFirm Scientific Publications
Publisher: OncoFirm Diagnostics Corporation
ISNI: 0000000530867315
© 2025 OncoFirm Diagnostics Corporation. All Rights Reserved.
OncoFirm™ is a biotechnology company developing innovative antigen-based diagnostic technologies designed to advance the early detection of cancer. Our proprietary fluorescent lateral flow platform combines rapid testing, sensitive biomarker detection, and digital analysis to support the future of accessible, point-of-care cancer diagnostics.
Related Posts
Lead Medical Advisor – Statistics Director
Dejun (DJ) Tang, PhD Lead Medical Advisor & Director of Statistics Dr. Dejun “DJ” Tang serves as Lead Medical Advisor at OncoFirm™ Diagnostics, bringing more than 27 years of pharmaceutical,…
Researchers – Fluorescent Lateral Flow Markers
Researchers – Fluorescent Lateral Flow Markers Company: OncoFirm™ Diagnostics CorporationDepartment: Research & Development / Assay DevelopmentPosition Type: Research / Scientific Collaboration / Contract or Grant-SupportedField: Fluorescent Lateral Flow Immunoassays, Biomarkers,…
Senior Scientist – Oncology & Molecular Diagnostics
Matthew Koslow, PhD Dr. Matthew Koslow is a molecular and cellular biologist with experience spanning oncology, drug discovery, molecular biology, translational research, and preclinical development. He brings a multidisciplinary scientific…
Lead Microfluidics & Diagnostic Engineer
Ting-Wen Lo, PhD Dr. Ting-Wen Lo is a biomedical researcher and chemical engineer with extensive experience in microfluidics, in vitro diagnostic technologies, biomarker analysis, molecular biology, and the development of…